EFFIPURE Trademark

Trademark Overview


On Wednesday, May 7, 2003, a trademark application was filed for EFFIPURE with the United States Patent and Trademark Office. The USPTO has given the EFFIPURE trademark a serial number of 78246735. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, October 13, 2005. This trademark is owned by EXACT Sciences Corporation. The EFFIPURE trademark is filed in the Pharmaceutical Products category with the following description:

Reagents for clinical medical use; Reagents for clinical medical use in binding assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagents for clinical medical use in diagnostic elect...

General Information


Serial Number78246735
Word MarkEFFIPURE
Filing DateWednesday, May 7, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, October 13, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 20, 2004

Trademark Statements


Goods and ServicesReagents for clinical medical use; Reagents for clinical medical use in binding assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in food products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination in food products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect pathogenic contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect food contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect blood contamination; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens in platelet products; Reagent kits comprised of reagents for clinical medical use; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagent kits comprised of reagents for clinical medical use, namely assays to detect nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; and Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 16, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEXACT Sciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Party NameEXACT Sciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events


Event DateEvent Description
Tuesday, December 13, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, December 13, 2005ABANDONMENT - NO USE STATEMENT FILED
Friday, June 17, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 17, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 5, 2005EXTENSION 1 GRANTED
Wednesday, March 30, 2005EXTENSION 1 FILED
Wednesday, March 30, 2005FAX RECEIVED
Tuesday, October 12, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2004NOTICE OF PUBLICATION
Monday, May 3, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 2, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 2, 2004PAPER RECEIVED
Monday, November 17, 2003UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, November 17, 2003PAPER RECEIVED
Wednesday, October 15, 2003NON-FINAL ACTION MAILED
Monday, October 6, 2003ASSIGNED TO EXAMINER
Wednesday, August 6, 2003PAPER RECEIVED